MCID: NRR001
MIFTS: 42

Neuroretinitis malady

Categories: Eye diseases, Neuronal diseases

Aliases & Classifications for Neuroretinitis

Aliases & Descriptions for Neuroretinitis:

Name: Neuroretinitis 12 14 69
Juxtapapillary Focal Retinitis and Retinochoroiditis 12 69
Retinitis 42 69
Focal Retinitis and Retinochoroiditis, Juxtapapillary 12
Papilloretinitis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10176
ICD10 33 H30.9
MeSH 42 D012173
SNOMED-CT 64 410471004
UMLS 69 C0154874

Summaries for Neuroretinitis

MalaCards based summary : Neuroretinitis, also known as juxtapapillary focal retinitis and retinochoroiditis, is related to syphilis and cysticercosis. An important gene associated with Neuroretinitis is CD40LG (CD40 Ligand). The drugs 4-Aminopyridine and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and brain, and related phenotypes are homeostasis/metabolism and hematopoietic system

Wikipedia : 71 Cat-scratch disease (CSD) is a common and usually benign infectious disease caused by the bacterium... more...

Related Diseases for Neuroretinitis

Diseases related to Neuroretinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 104)
id Related Disease Score Top Affiliating Genes
1 syphilis 29.9 CD40LG EXTL3
2 cysticercosis 29.9 CD40LG EXTL3
3 irvan syndrome 11.8
4 retinitis 10.3
5 mild pre-eclampsia 10.3 CD40LG EXTL3
6 diabetic peripheral angiopathy 10.3 CD40LG EXTL3
7 heart septal defect 10.3 CD40LG RNASE3
8 tuberculous pneumothorax 10.3 ACE CD40LG
9 ametropic amblyopia 10.3 CD40LG EXTL3
10 cerebral neuroblastoma 10.3 CD40LG EXTL3
11 adrenal gland disease 10.3 CD40LG EXTL3
12 vasculitis 10.3
13 retinal vasculitis 10.3
14 atypical breast papilloma 10.3 CD40LG EXTL3
15 aneurysm 10.3
16 muscular dystrophy 10.3 CD40LG EXTL3
17 adrenal gland ganglioneuroblastoma 10.3 CD40LG TNFRSF10A
18 hypercalcemic sarcoidosis 10.2 ACE LYZ
19 cat-scratch disease 10.2
20 central gyrate choroidal dystrophy 10.2 CD40LG RNASE3
21 schwannoma of twelfth cranial nerve 10.2 AQP4 CD40LG MOG
22 newcastle disease 10.2 ACE CD40LG LYZ
23 central nervous system leiomyosarcoma 10.2 CA2 LYZ VEGFA
24 acute chest syndrome 10.2 ACE CD40LG RNASE3
25 ureteral lymphoma 10.2 CD40LG RNASE3 TNFRSF10A
26 homocystinuria 10.1 CD40LG TNFRSF10A
27 placenta accreta 10.1 CD40LG RNASE3
28 tuberculosis 10.1 ACE CD40LG IFNB1
29 liver rhabdomyosarcoma 10.1 CD40LG LYZ
30 crest syndrome 10.1 AQP4 IFNB1
31 calcinosis 10.1 ACE CD40LG LYZ
32 clear cell adenoma 10.1 AQP4 IFNB1 MOG
33 testicular lymphoma 10.1 ACE CD40LG MLN
34 neonatal jaundice 10.1 AQP4 IFNB1 MOG
35 spondyloarthropathy 2 10.0 ACE VEGFA
36 complex regional pain syndrome 10.0 AQP4 CD40LG IFNB1 MOG
37 advanced sleep phase syndrome, familial, 1 10.0 AQP4 CD40LG IFNB1 MOG
38 allergic contact dermatitis of eyelid 9.9 AQP4 MOG UBL4A
39 substance-induced psychosis 9.9 AQP4 CD40LG IFNB1 MOG VEGFA
40 lyme disease 9.8
41 toxoplasmosis 9.8
42 choroiditis 9.8
43 toxocariasis 9.8
44 bartonellosis 9.8
45 antiphospholipid syndrome 9.7
46 ocular hypertension 9.7
47 meningitis 9.7
48 retinal detachment 9.7
49 uveitis 9.7
50 hypertensive retinopathy 9.6

Graphical network of the top 20 diseases related to Neuroretinitis:



Diseases related to Neuroretinitis

Symptoms & Phenotypes for Neuroretinitis

MGI Mouse Phenotypes related to Neuroretinitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.06 ACE AQP4 CA2 CD40LG EXTL3 FLNA
2 hematopoietic system MP:0005397 10.02 ACE AQP4 CD40LG FLNA IFNB1 LYZ
3 endocrine/exocrine gland MP:0005379 10.01 VEGFA ACE AQP4 CA2 CD40LG EXTL3
4 immune system MP:0005387 9.96 ACE AQP4 CA2 CD40LG FLNA IFNB1
5 nervous system MP:0003631 9.81 AQP4 CA2 CD40LG DPYSL5 FLNA IFNB1
6 no phenotypic analysis MP:0003012 9.43 AQP4 IFNB1 LYZ TNFRSF10A UBL4A VEGFA
7 renal/urinary system MP:0005367 9.1 ACE AQP4 CA2 CD40LG LYZ VEGFA

Drugs & Therapeutics for Neuroretinitis

Drugs for Neuroretinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 392)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
4-Aminopyridine Approved Phase 4 504-24-5 1727
2
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
3
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
4
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
5
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
6
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
7
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
8
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Early Phase 1 437-38-7 3345
10
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
11
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
12
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
13
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
14
Lymecycline Approved Phase 4 992-21-2 5280963
15
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
16
Aluminum hydroxide Approved Phase 4,Phase 2 21645-51-2
17
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
18
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
19
Imipramine Approved Phase 4 50-49-7 3696
20
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
21
Clozapine Approved Phase 4 5786-21-0 2818
22
Insulin Detemir Approved Phase 4 169148-63-4 5311023
23
Zinc Approved Phase 4,Phase 3 7440-66-6 32051 23994
24
Capsaicin Approved Phase 4 404-86-4 1548943
25
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757 53477783
26
Everolimus Approved Phase 4,Phase 2 159351-69-6 6442177
27
Sirolimus Approved, Investigational Phase 4,Phase 2 53123-88-9 5284616 6436030 46835353
28
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
29
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
30
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
31
Leuprolide Approved, Investigational Phase 4,Phase 1 53714-56-0 3911 657181
32
Pantoprazole Approved Phase 4 102625-70-7 4679
33
Tamoxifen Approved Phase 4 10540-29-1 2733526
34
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 14219 4091
35
Ganirelix Approved Phase 4 123246-29-7, 124904-93-4 25081094
36
Menotropins Approved Phase 4 61489-71-2 5360545
37
Methylnaltrexone Approved Phase 4 83387-25-1, 916055-93-1 6603824
38
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
39
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
40
Ticagrelor Approved Phase 4 274693-27-5 9871419
41
Furosemide Approved, Vet_approved Phase 4,Phase 1 54-31-9 3440
42
Paclitaxel Approved, Vet_approved Phase 4 33069-62-4 36314
43
Caffeine Approved, Nutraceutical Phase 4 58-08-2 2519
44
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
45
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 3 67-97-0 6221 10883523 5280795
46
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-14-6 5280793
47 Potassium Channel Blockers Phase 4
48 Adjuvants, Anesthesia Phase 4,Early Phase 1
49 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 358)
id Name Status NCT ID Phase
1 Resistance Training and Amino Pyridine in Multiple Sclerosis Unknown status NCT02143167 Phase 4
2 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4
3 Optimal Multimodal Analgesia in Abdominal Hysterectomy Unknown status NCT00209872 Phase 4
4 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4
5 SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents Unknown status NCT00714545 Phase 4
6 Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety. Unknown status NCT02226328 Phase 4
7 Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair Unknown status NCT01326039 Phase 4
8 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4
9 Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial Unknown status NCT02477371 Phase 4
10 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
11 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4
12 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4
13 Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair Unknown status NCT00960011 Phase 4
14 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Completed NCT02625103 Phase 4
15 Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Completed NCT01308554 Phase 4
16 Santyl vs. Sharp Debridement of Diabetic Foot Wounds Completed NCT01056198 Phase 4
17 Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients Completed NCT00742976 Phase 4
18 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Completed NCT01656148 Phase 4
19 Effects of NSK-SD (Nattokinase) on Blood Pressure Completed NCT02886507 Phase 4
20 The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods Completed NCT01048515 Phase 4
21 Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy Completed NCT01934088 Phase 4
22 Bilateral Dual TAP Block: Description of a Novel Four-point Approach Completed NCT01040234 Phase 4
23 Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls Completed NCT00115102 Phase 4
24 The Effect of Calcium and Vitamin D in Patients With Heart Failure Completed NCT00497900 Phase 4
25 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4
26 Myocardial Damage In Patients With Cerebral Infarction Completed NCT00306579 Phase 4
27 Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome Completed NCT00134745 Phase 4
28 The SORT OUT IX STEMI OCT Trial Recruiting NCT02915107 Phase 4
29 Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Recruiting NCT02484105 Phase 4
30 Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) Recruiting NCT02824224 Phase 4
31 Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery Recruiting NCT03044808 Phase 4
32 Corticosteroid Reduction in COPD Recruiting NCT02857842 Phase 4
33 Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Recruiting NCT02797340 Phase 4
34 Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation Recruiting NCT02069808 Phase 4
35 Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients Recruiting NCT02942550 Phase 4
36 Forced Fluid Removal in High Risk Acute Kidney Injury Recruiting NCT02458157 Phase 4
37 Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD Recruiting NCT02567214 Phase 4
38 Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis Recruiting NCT02831608 Phase 4
39 Pan European Collaboration on Antipsychotic Naïve Schizophrenia II Recruiting NCT02339844 Phase 4
40 Stress Ulcer Prophylaxis in the Intensive Care Unit Recruiting NCT02467621 Phase 4
41 BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Active, not recruiting NCT02623140 Phase 4
42 The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting Not yet recruiting NCT01534221 Phase 4
43 The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study Terminated NCT01899235 Phase 4
44 Trial for Single Port Versus Conventional Laparoscopic Colectomy Unknown status NCT01101672 Phase 2, Phase 3
45 Lung Protective Ventilation During Robotic Assisted Prostatectomy Completed NCT02551341 Phase 3
46 Nucleoplasty for Contained Herniated Lumbar Discs Completed NCT00124774 Phase 3
47 Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial Completed NCT01304927 Phase 2, Phase 3
48 The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET Completed NCT00747968 Phase 2, Phase 3
49 Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis Completed NCT00864383 Phase 3
50 Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) Completed NCT01950936 Phase 2, Phase 3

Search NIH Clinical Center for Neuroretinitis

Cochrane evidence based reviews: retinitis

Genetic Tests for Neuroretinitis

Anatomical Context for Neuroretinitis

MalaCards organs/tissues related to Neuroretinitis:

39
Eye, Retina, Brain, Lung, Testes, Kidney

Publications for Neuroretinitis

Articles related to Neuroretinitis:

(show top 50) (show all 289)
id Title Authors Year
1
Neuroretinitis as presenting and the only presentation of Lyme disease: Diagnosis and management. ( 28440258 )
2017
2
Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in BehAset's Disease. ( 27065852 )
2016
3
Fluorescein Photodiagnosis of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome: A Case Report and Long-Term Outcome of Photocoagulation Therapy. ( 27491854 )
2016
4
Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient presenting with idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 26922651 )
2016
5
Choroidal neovascularization complicating optic disc drusen, mistaken for Bartonella neuroretinitis. ( 27730317 )
2016
6
BARTONELLA QUINTANA-ASSOCIATED NEURORETINITIS: LONGITUDINAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHIC FINDINGS. ( 27258542 )
2016
7
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma. ( 27165193 )
2016
8
Toxoplasmosis Neuroretinitis: A Case Report. ( 27340559 )
2016
9
Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient. ( 27525478 )
2016
10
Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. ( 27195096 )
2016
11
Diffuse Unilateral Subacute Neuroretinitis From Raccoon Exposure Resistant to Laser Photocoagulation. ( 27434904 )
2016
12
Bilateral neovascular glaucoma in idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 27085273 )
2016
13
Clinical experience in treatment of diffuse unilateral subretinal neuroretinitis. ( 26491239 )
2015
14
Neuroretinitis with dual infections. ( 26527902 )
2015
15
Diffuse unilateral subacute neuroretinitis in a healthy Korean male: the first case report in Korea. ( 25729261 )
2015
16
Neuroretinitis in ocular bartonellosis. ( 25453244 )
2015
17
An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292952 )
2015
18
Lyme disease associated neuroretinitis - Case report. ( 26689876 )
2015
19
Systemic Lupus Erythematosus Presenting as Neuroretinitis. ( 27608700 )
2015
20
Optical Coherence Tomography Features in Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis Syndrome. ( 26425325 )
2015
21
A rare case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome. ( 26265851 )
2015
22
GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. ( 25837926 )
2015
23
The natural history of idiopathic neuroretinitis. ( 26116629 )
2015
24
Re: An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292953 )
2015
25
Teaching NeuroImages: Cat-scratch optic neuropathy without neuroretinitis. ( 26078406 )
2015
26
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome. ( 26441263 )
2015
27
Full-thickness macular hole in Bartonella henselae neuroretinitis in an 11-year-old girl. ( 25709274 )
2015
28
Final Diagnosis in Patients Referred with a Diagnosis of Neuroretinitis. ( 27928367 )
2015
29
An Atypical Presentation of Bartonella Neuroretinitis. ( 26447400 )
2015
30
Atypical neuroretinitis in secondary chickenpox. ( 25950465 )
2015
31
Bilateral stellate neuroretinitis revealing a pheochromocytoma. ( 25995810 )
2015
32
Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma. ( 23948465 )
2014
33
Neuroretinitis secondary to Bartonella henselae in the emergent setting. ( 25586979 )
2014
34
Multimodal Imaging Assisting the Early Diagnosis of Cat-Scratch Neuroretinitis. ( 25412327 )
2014
35
Unilateral neuroretinitis secondary to Bartonella henselae infection. ( 24106074 )
2014
36
Neuroretinitis secondary to Bartonella henselae in the emergent setting. ( 25497596 )
2014
37
Subretinal Thelazia-induced diffuse unilateral subacute neuroretinitis. ( 25010173 )
2014
38
Dynamics of intraretinal fluid accumulation evidenced by SD-OCT in a case of cat scratch neuroretinitis. ( 24625384 )
2014
39
Neuroretinitis in ocular bartonellosis: a case series. ( 25120352 )
2014
40
Should patients with bartonella neuroretinitis receive treatment? ( 25405664 )
2014
41
A star in the eye: cat scratch neuroretinitis. ( 25356231 )
2014
42
Evaluation of patients with diffuse unilateral subacute neuroretinitis by spectral domain optical coherence tomography with enhanced depth imaging. ( 24940045 )
2014
43
Chronic meningitis with intracranial hypertension and bilateral neuroretinitis following Mycoplasma pneumoniae infection. ( 25538215 )
2014
44
Phaeochromocytoma revealed by a stellate neuroretinitis. ( 25182462 )
2014
45
Neuroretinitis with abnormal brain imaging in Ask-Upmark kidney: A novel case report. ( 25250080 )
2014
46
Subacute idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) in a child and review of paediatric cases of IRVAN revealing preserved capillary perfusion as a more common feature. ( 25233821 )
2014
47
Bilateral neuroretinitis and retinal hemorrhages in an immunocompetent patient. ( 25320946 )
2014
48
Central scotoma without prodromal illness caused by Bartonella henselae neuroretinitis. ( 23481153 )
2013
49
Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder. ( 24081683 )
2013
50
Detection of glaucoma with an optical coherence tomography-derived neuroretinal rim parameter. ( 24182570 )
2013

Variations for Neuroretinitis

Expression for Neuroretinitis

Search GEO for disease gene expression data for Neuroretinitis.

Pathways for Neuroretinitis

GO Terms for Neuroretinitis

Cellular components related to Neuroretinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.56 ACE CD40LG FLNA IFNB1 LYZ MLN
2 extracellular space GO:0005615 9.17 ACE CA2 CD40LG IFNB1 LYZ RNASE3

Biological processes related to Neuroretinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 kidney development GO:0001822 9.13 ACE CA2 VEGFA
2 positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086 8.62 ACE VEGFA

Sources for Neuroretinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....